FDAnews Device Daily Bulletin

nContact Gets IDE to Research Closed-Chest Convergent Ablation Procedure

April 20, 2010
nContact Surgical, Inc Monday announced it has received the first Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration to evaluate the safety and efficacy of a combined surgical and catheter procedure (the convergent procedure) to treat patients with longstanding persistent atrial fibrillation.